10-14 – Oral Administration Of Meloxicam in Cattle to Increase Growth After Dehorning and to Reduce the Incidence of Bovine Respiratory Disease After Castration

Research at Kansas State University has shown that the novel use of meloxicam administered by mouth to calves at 1 mg/kg reduces the incidence of bovine respiratory disease (BRD) after castration and increases the rate of weight gain after dehorning. In the U.S., at least 4 M calves/ year are dehorned and producers castrate at least 8 M calves/year (NASS, 2010). Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class that is approved in the EU for adjunctive therapy of acute respiratory disease; diarrhea and acute mastitis in cattle when administered at 0.5 mg/kg IM or SC. There are no approved oral formulations of meloxicam for use in cattle. Bret Ford bretford@ksu.edu 785-532-3924

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More